IDO1 and colorectal carcinoma: Notable inhibitors include 1-MT (Table 2), a canonical IDO inhibitor with low toxicity, and its isomer 1-L-MT, which induces mitochondrial damage, reduces CRC cell proliferation, and inhibits CRC development in vivo [67, 89].